The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Long-term Cardiovascular Mortality Among Middle-aged Men With Gout
Abstract
BACKGROUND: There are limited data available on the association of gouty arthritis (gout) in middle age with long-term cardiovascular disease (CVD) mortality. METHODS: We performed a 17-year follow-up study of 9105 men, aged 41 to 63 years and at above-average risk for coronary heart disease, who were randomized to the Multiple Risk Factor Intervention Trial and who did not die or have clinical or electrocardiographic evidence of coronary artery disease during the 6-year trial. Risk of CVD death and other causes subsequent to the sixth annual examination associated with gout was assessed by means of Cox proportional hazards regressions. RESULTS: The unadjusted mortality rates from CVD among those with and without gout were 10.3 per 1000 person-years and 8.0 per 1000 person-years, respectively, representing an approximately 30% greater risk. After adjustment for traditional risk factors, use of diuretics and aspirin, and serum creatinine level, the hazard ratio (gout vs no gout) for coronary heart disease mortality was 1.35 (95% confidence interval [CI], 1.06-1.72). The hazard ratio for death from myocardial infarction was 1.35 (95% CI, 0.94-1.93); for death from CVD overall, 1.21 (95% CI, 0.99-1.49); and for death from any cause, 1.09 (95% CI, 1.00-1.19) (P = .04). The association between hyperuricemia and CVD was weak and did not persist when analysis was limited to men with hyperuricemia without a diagnosis of gout. CONCLUSION: Among middle-aged men, a diagnosis of gout accompanied by an elevated uric acid level imparts significant independent CVD mortality risk. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00000487.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Blood Pressure and End-Stage Renal Disease in Men
Klag, M. J., Whelton, P. K., Randall, B. L., Neaton, J. D., Brancati, F. L., Ford, C. E., Shulman, N. B., & Stamler, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340103 · Cited by 1,663
Preliminary criteria for the classification of the acute arthritis of primary gout
Wallace, S. L., Robinson, H., Masi, A. T., Decker, J. L., Mccarty, D. J., & Yü, T. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200320 · Cited by 1,432
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Asymptomatic hyperuricemia. Risks and consequences in the normative aging study
Campion, E. W., Glynn, R. J., & Delabry, L. O. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90441-4 · Cited by 851
Sautin, Y. Y., Nakagawa, T., Zharikov, S., & Johnson, R. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00600.2006 · Cited by 787
Fröhlich, M., Imhof, A., Berg, G., Hutchinson, W. L., Pepys, M. B., Boeing, H., Muche, R., Brenner, H., & Koenig, W. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1835 · Cited by 688
Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease
Choi, H. K., & Curhan, G. (2007) · Circulation · doi:10.1161/circulationaha.107.703389 · Cited by 666
End-stage renal disease in African-American and white men. 16-year MRFIT findings
Klag, M. J. (1997) · JAMA · doi:10.1001/jama.277.16.1293 · Cited by 612
Uric acid and inflammatory markers
Ruggiero, C., Cherubini, A., Ble, A., Bos, A. J. G., Maggio, M., Dixit, V. D., Lauretani, F., Bandinelli, S., Senin, U., & Ferrucci, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi879 · Cited by 591
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease
Kanellis, J., & Kang, D.-H. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.09.007 · Cited by 443
Gout and the risk of acute myocardial infarction
Krishnan, E., Baker, J. F., Furst, D. E., & Schumacher, H. R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22014 · Cited by 430
Self-citationGout and coronary heart disease: The framingham study
Abbott, R. D., Brand, F. N., Kannel, W. B., & Castelli, W. P. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90127-8 · Cited by 355
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
Baker, J. F., Krishnan, E., Chen, L., & Schumacher, H. R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.043 · Cited by 354
Self-citationUric acid in chronic heart failure: a marker of chronic inflammation
Leyva, F. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1188 · Cited by 287
Santos, C. X. C., Anjos, E. I., & Augusto, O. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1491 · Cited by 274
Wentworth, D. N., Neaton, J. D., & Rasmussen, W. L. (1983) · American Journal of Public Health · doi:10.2105/ajph.73.11.1270 · Cited by 222
LEVINE, W. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90061-9 · Cited by 217
Mechanisms of inflammation in gout
Dalbeth, N., & Haskard, D. O. (2005) · Rheumatology · doi:10.1093/rheumatology/keh640 · Cited by 210
Pascual, E. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340203 · Cited by 180
COUTINHO, T., TURNER, S., PEYSER, P., BIELAK, L., SHEEDYII, P., & KULLO, I. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.06.015 · Cited by 180
Shemesh, J., Morag‐Koren, N., Goldbourt, U., Grossman, E., Tenenbaum, A., Fisman, E. Z., Apter, S., Itzchak, Y., & Motro, M. (2004) · Journal of Hypertension · doi:10.1097/00004872-200403000-00024 · Cited by 68
Tsutsumi, Z., Moriwaki, Y., Takahashi, S., Ka, T., & Yamamoto, T. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.09.019 · Cited by 32
Vascular mortality in patients with gout and in their families.
Darlington, L. G., Slack, J., & Scott, J. T. (1983) · Annals of the Rheumatic Diseases · doi:10.1136/ard.42.3.270 · Cited by 12
Cited by
Zhu, Y., Pandya, B. J., & Choi, H. K. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30520 · Cited by 1,785
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Richette, P., & Bardin, T. (2010) · The Lancet · doi:10.1016/s0140-6736(09)60883-7 · Cited by 915
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
White, W. B., Saag, K. G., Becker, M. A., Borer, J. S., Gorelick, P. B., Whelton, A., Hunt, B., Castillo, M., & Gunawardhana, L. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710895 · Cited by 909
Metadata
- Authors
- Krishnan, E.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2008-05-26
- Volume
- 168
- Issue
- 10
- Pages
- 1104
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2022503135
- Cited by
- 328
- References
- 24
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.